Header Logo

Connection

DAVID LONARD to Recombinant Fusion Proteins

Back to Details
This is a "connection" page, showing publications DAVID LONARD has written about Recombinant Fusion Proteins.
DAVID LONARD
Connection Strength
0.044
Recombinant Fusion Proteins
  1. Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins. Mol Cell Biol. 2004 Jan; 24(1):14-24.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.